On the other hand, neurons treated with DLB BDTOs, pretreated with CL3, displayed increased monomeric tau in the nuclear fraction as compared with those neurons treated with untreated DLB BDTOs and comparable with the untreated neurons. This evidence concerns the gene MAPT and Lewy body dementia.